SNSE
NASDAQ · Biotechnology
Sensei Biotherapeutics Inc
$8.86
-0.04 (-0.45%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.00M | 5.90M | 5.57M |
| Net Income | -817,172 | -706,875 | -767,435 |
| EPS | — | — | — |
| Profit Margin | -13.6% | -12.0% | -13.8% |
| Rev Growth | +2.3% | +18.9% | +16.5% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 1.60M | 1.40M | 1.77M |
| Total Equity | 8.78M | 8.51M | 8.18M |
| D/E Ratio | 0.18 | 0.16 | 0.22 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | -1,135,758 | -954,399 | -978,652 |
| Free Cash Flow | -597,971 | -436,320 | -559,358 |